SEC Comment Letter 0000000000-25-009447 to Tharimmune, Inc. (THAR) (CIK 0001861657) (THAR)
Tharimmune, Inc. (THAR) (CIK 0001861657)
Date: Sept. 2, 2025 · CIK: 0001861657 · Accession: 0000000000-25-009447
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289869
Letter
Re: Tharimmune, Inc. Registration Statement on Form S-3 Filed August 26, 2025 File No. 333-289869 Dear Sireesh Appajosyula:
September 2, 2025
Sireesh Appajosyula Chief Executive Officer Tharimmune, Inc. 34 Shrewsbury Avenue Red Bank, NJ 07701
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Scott E. Linsky, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> September 2, 2025 Sireesh Appajosyula Chief Executive Officer Tharimmune, Inc. 34 Shrewsbury Avenue Red Bank, NJ 07701 Re: Tharimmune, Inc. Registration Statement on Form S-3 Filed August 26, 2025 File No. 333-289869 Dear Sireesh Appajosyula: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Scott E. Linsky, Esq. </TEXT> </DOCUMENT>